Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Bone. 2011 Dec 10;50(3):743–748. doi: 10.1016/j.bone.2011.12.001

Table 3.

Multi-linear regression analyses relating five-year percentage changes in FStance and FFall to age, gender, self-reported health score, history of use of bone active medications and change in weight between the baseline and five-year visit.

GENDER POOLED *#
FStance FFall
Term β Std Error p β Std Error p
Intercept 14.29 8.66 0.1 16.2 12.48 0.2
Baseline Age (years) −0.265 0.11 0.02 −0.365 0.16 0.026
Gender 2.49 0.65 0.0002 2.64 0.935 0.005
Health Score −0.425 0.53 0.43 0.405 0.765 0.597
Bone Active Meds 3.315 1.34 0.01 1.89 1.93 0.329
Weight Change (kg) 0.19 0.12 0.11 −0.03 0.17 0.859
MEN
FStance FFall
Term β Std Error p β Std Error p
Intercept 24.235 12.455 0.05 44.255 16.53 0.009
Baseline Age (years) −0.405 0.165 0.015 −0.695 0.22 0.002
Health Score 0.625 0.805 0.44 0.475 1.07 0.658
Bone Active Meds 6.705 2.315 0.005 −0.765 3.07 0.804
Weight Change (kg) −0.075 0.17 0.664 −0.315 0.22 0.156
WOMEN
FStance FFall
Term β Std Error p β Std Error p
Intercept 8.75 11.555 0.451 −13.71 18.715 0.465
Baseline Age (years) −0.17 0.145 0.245 −0.02 0.24 0.932
Health Score −1.225 0.67 0.071 0.62 1.09 0.571
Bone Active Meds 1.165 1.52 0.446 3.485 2.465 0.16
Weight Change (kg) 0.49 0.165 0.003 0.27 0.265 0.311
*

: gender*weight loss interaction was significant (p=0.03) for FStance but not FFall

#

gender*age interaction was significant (p=0.04) for FFall but not FStance